Here we used a mouse model of genetically attenuated reactive gliosis (mice deficient for IF proteins GFAP and vimentin) to determine the impact of ischemia-induced reactive gliosis on the regenerative capacity of transplanted human iPSC-derived NSPCs. The gene discussed is VIM; the disease is Gliosis.